These ready-to-use red blood cells can be used for antibody detection in Essange Reagents’ Cellbind immunofixation system, which is based on antigen/antibody reaction. The cells are used to screen and/or identify sera for the presence of red cell antibodies.
Cellbind P2 and P3 screening panels consists of 10 ml vials. The cells are suspended in a special preservation medium. All cell suspensions are derived from individual donors possessing blood group O. The red blood cell suspensions (0.5%) used in this screening panel have been selected so as to ensure optimal antigen distribution for the detection of clinically significant red cell antibodies.
A donor positive for Cw-antigen is always present. The fact that the donors used in this panel are often homozygous for the genes controlling the antigens present on their red cells renders screening panel 123 suitable for use in type and screen procedures. Cellbind P2 and Cellbind P3 screening panels always contains Bga-, Bgb- and Bgc negative donors.
The Cellbind ID16 identification panel consists of 3 ml vials with 16 different cell suspensions (0.5%), derived from individual donors all with blood group O. The Cellbind ID16 panel cells have been selected in a specific manner to ensure optimal antigen distribution for the identification of clinically significant red cell antibodies in 97% of the cases.
An extra advantage is the presence of a Kpa positive cell, a Lua positive cell, a RzR2 cell, a k negative cell and a Wra positive cell.
Red blood cells for confirmation of ABO groups
Ready-to-use red cell suspensions for the detection of allo-antibodies anti-A and anti-B (A1 and B reagent red cells) and for the use as positive or negative control (O positive, and A2 reagent red cells).